Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls. — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(2 sites)
United States
University of Texas Southwestern Medical Center, Dallas, Texas Spain
Sant Joan de Deu, Barcelona Age range
21 Months – 78 Months
Last updated January 2026